Stalevo 100 mg/25 mg/200 mg film-coated tablets

Company
Orion Pharma (Ireland) Ltd
Active Ingredient
Dosage Form
Infus/Pdr/Oral Soln
Legal Category
B - prescription, may be renewed
Date of revision
01/2022

*further information is available on request to the holder of the authorisation or in the SPC

Licence number Strength ATC Code Dosage Form
EU/1/03/260/005 N04BA, N04BA03 Infus/Pdr/Oral Soln
EU/1/03/260/006 N04BA, N04BA03 Infus/Pdr/Oral Soln
EU/1/03/260/007 N04BA, N04BA03 Infus/Pdr/Oral Soln
EU/1/03/260/008 N04BA, N04BA03 Infus/Pdr/Oral Soln
EU/1/03/260/14 N04BA, N04BA03 Infus/Pdr/Oral Soln
EU/1/03/260/17 N04BA, N04BA03 Infus/Pdr/Oral Soln
Licence number
EU/1/03/260/005
Strength
–
ATC Code
N04BA, N04BA03
Dosage Form
Infus/Pdr/Oral Soln
Licence number
EU/1/03/260/006
Strength
–
ATC Code
N04BA, N04BA03
Dosage Form
Infus/Pdr/Oral Soln
Licence number
EU/1/03/260/007
Strength
–
ATC Code
N04BA, N04BA03
Dosage Form
Infus/Pdr/Oral Soln
Licence number
EU/1/03/260/008
Strength
–
ATC Code
N04BA, N04BA03
Dosage Form
Infus/Pdr/Oral Soln
Licence number
EU/1/03/260/14
Strength
–
ATC Code
N04BA, N04BA03
Dosage Form
Infus/Pdr/Oral Soln
Licence number
EU/1/03/260/17
Strength
–
ATC Code
N04BA, N04BA03
Dosage Form
Infus/Pdr/Oral Soln

Orion Pharma (Ireland) Ltd

c/o Allphar Services Ltd, 4045 Kingswood Road, Citywest Business Park, Co Dublin D24V06K

Website
https://www.orionpharma.ie
Telephone
+35314688482
Email
ie.medicalinformation@orionpharma.com